Bicycle Therapeutics plc Increase (Decrease) in Other Operating Assets
Bicycle Therapeutics plc (BCYC) reported Increase (Decrease) in Other Operating Assets of $2.64 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2022-11-03
- Bicycle Therapeutics plc increase (decrease) in other operating assets for the quarter ending 2022-09-30 was $1.02M, a 155.36% increase year-over-year.
- Bicycle Therapeutics plc increase (decrease) in other operating assets for the quarter ending 2022-06-30 was $868.00K, a 331.84% increase year-over-year.
- Bicycle Therapeutics plc increase (decrease) in other operating assets for the quarter ending 2022-03-31 was $748.00K, a 111.90% increase year-over-year.
- Bicycle Therapeutics plc increase (decrease) in other operating assets for the quarter ending 2021-12-31 was $667.00K.
- Bicycle Therapeutics plc increase (decrease) in other operating assets for fiscal 2021 was $1.62M, a 1229.51% increase from fiscal 2020.
- Bicycle Therapeutics plc increase (decrease) in other operating assets for fiscal 2020 was $122.00K, a 69.27% decline from fiscal 2019.
- Bicycle Therapeutics plc increase (decrease) in other operating assets for fiscal 2019 was $397.00K, a 31.89% increase from fiscal 2018.
- Bicycle Therapeutics plc increase (decrease) in other operating assets for fiscal 2018 was $301.00K, a 71.03% decline from fiscal 2017.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2022-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.89M derived: sum of 2 quarters · filed 2022-11-03 | $2.64M 10-Q · filed 2022-11-03 | $3.31M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | $868.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.62M 10-Q · filed 2022-08-04 | $2.28M derived: sum of 3 quarters · filed 2022-08-04 | $2.68M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-03-31 | $748.00K 10-Q · filed 2022-05-05 | $1.42M derived: sum of 2 quarters · filed 2022-05-05 | $1.82M derived: sum of 3 quarters · filed 2022-11-03 | $2.02M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-12-31 | $667.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.07M derived: sum of 2 quarters · filed 2022-11-03 | $1.27M derived: sum of 3 quarters · filed 2022-11-03 | $1.62M 10-K · filed 2022-03-01 |
| 2021-09-30 | $401.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $602.00K derived: sum of 2 quarters · filed 2022-11-03 | $955.00K 10-Q · filed 2022-11-03 | $358.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $201.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $554.00K 10-Q · filed 2022-08-04 | -$43.00K derived: sum of 3 quarters · filed 2022-08-04 | $384.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $353.00K 10-Q · filed 2022-05-05 | -$244.00K derived: sum of 2 quarters · filed 2022-05-05 | $183.00K derived: sum of 3 quarters · filed 2022-05-05 | $260.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$597.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$170.00K derived: sum of 2 quarters · filed 2022-03-01 | -$93.00K derived: sum of 3 quarters · filed 2022-03-01 | $122.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $427.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $504.00K derived: sum of 2 quarters · filed 2021-11-04 | $719.00K 10-Q · filed 2021-11-04 | $900.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $292.00K 10-Q · filed 2021-08-05 | $473.00K derived: sum of 3 quarters · filed 2022-03-01 | $565.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $215.00K 10-Q · filed 2021-05-06 | $396.00K derived: sum of 2 quarters · filed 2022-03-01 | $488.00K derived: sum of 3 quarters · filed 2022-03-01 | $737.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $181.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $273.00K derived: sum of 2 quarters · filed 2022-03-01 | $522.00K derived: sum of 3 quarters · filed 2022-03-01 | $397.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $92.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $341.00K derived: sum of 2 quarters · filed 2020-11-05 | $216.00K 10-Q · filed 2020-11-05 | $202.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | $249.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $124.00K 10-Q · filed 2020-08-05 | $110.00K derived: sum of 3 quarters · filed 2021-03-11 | $111.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | -$125.00K 10-Q · filed 2020-05-07 | -$139.00K derived: sum of 2 quarters · filed 2021-03-11 | -$138.00K derived: sum of 3 quarters · filed 2021-03-11 | |
| 2018-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$13.00K derived: sum of 2 quarters · filed 2021-03-11 | $301.00K 10-K · filed 2021-03-11 | |
| 2018-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $315.00K 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | $314.00K 10-Q · filed 2019-08-08 | |||
| 2017-12-31 | $1.04M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |